Development of an Integrated Screening Framework for Marine-Derived Bacillus Probiotics
Marine Drugs · 15.04.2026 · 24 (4) · 137
DOI: 10.3390/md24040137 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, online erschienen am 15.04.2026. Verfasst von Yaoying Lu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Biomedicine and Glycomics, Griffith University, Parklands Drive, Gold Coast, QLD 4222, Australia. Hauptthemen laut MEDLINE: Probiotics, Bacillus, Aquatic Organisms, Porifera. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Marine Bioproduct CRC, Marine Bioproducts Cooperative Research Centre.
Abstract (Originalsprache)
Probiotics are known to improve gut microbiota balance, enhance food digestion, and support overall health. Among these, Bacillus species are particularly promising due to their safety, spore-forming ability, environmental resilience, and diverse enzymatic activities. However, most Bacillus probiotics used in industry are of terrestrial origin, leaving marine-derived strains largely unexplored. Utilising the untapped potential of marine microbial biomass, this study presents a multi-stage methodology for identifying and evaluating marine-derived Bacillus strains with probiotic potential. A structured screening pipeline was applied to 67 microbial isolates from the Great Barrier Reef sponges. Initial selection focused on essential probiotic characteristics, including growth, stability, safety, and survival under gastrointestinal conditions. Strains meeting these criteria were then assessed for desirable properties, including digestive enzyme production and pathogen inhibition. Using this workflow, three marine-derived Bacillus strains were identified as potential probiotics, one of which demonstrated strong antimicrobial activity against Salmonella enterica at 5 and 10 mg/mL (p < 0.01). These findings demonstrate the capability of marine-associated Bacillus as novel bioproducts with functional antimicrobial properties.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Biomedicine and Glycomics, Griffith University, Parklands Drive, Gold Coast, QLD 4222, Australia.
- Bioproton Pty Ltd., 55 Dulacca St., Brisbane, QLD 4110, Australia.
- School of Environment and Science, Griffith University, 170 Kessels Road, Brisbane, QLD 4111, Australia.
ORCID-Profile: Yaoying Lu, Xiaojing Chen, Yunjiang Feng
Förderung
- Marine Bioproduct CRC
- Marine Bioproducts Cooperative Research Centre
Zitieren
APA
Lu, Y., Chen, X., & Feng, Y. (2026). Development of an Integrated Screening Framework for Marine-Derived Bacillus Probiotics. Marine Drugs, 24(4), 137. https://doi.org/10.3390/md24040137
Vancouver
Lu Y, Chen X, Feng Y. Development of an Integrated Screening Framework for Marine-Derived Bacillus Probiotics. Marine Drugs. 2026;24(4):137. doi:10.3390/md24040137
BibTeX
@article{Lu2026,
author = {Lu, Yaoying and Chen, Xiaojing and Feng, Yunjiang},
title = {Development of an Integrated Screening Framework for Marine-Derived Bacillus Probiotics},
journal = {Marine Drugs},
year = {2026},
volume = {24},
number = {4},
pages = {137},
doi = {10.3390/md24040137}
}
EUVIMED